Form D Explorer

Inspect source fieldsReport a record issue

Form D — PIPr Therapeutics, Inc.

0001687466-25-000004 · filed Nov 12, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$2,499,992
Reported amount sold
$1,499,995
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
PIPr Therapeutics, Inc.
CIK
1687466
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
280 S. MANGUM ST.
DURHAM, North Carolina 27701
Phone
9193578326

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗